APLN and diabetic cardiomyopathy: Due to the inotropic properties and vasodilation induced by apelin, plasma apelin enhancement appears to be a compensatory mechanism for maintaining cardiac output in rats with hypertensive overload or diabetic cardiomyopathy (148).